DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer.

DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer.

Item
http://www.wikidata.org/entity/Q38893748
IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway.Oxidative stress-induced CREB upregulation promotes DNA damage repair prior to neuronal cell death protection.Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas.ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells.ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.Oxidative stress and prostatic diseases.Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer.Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer.ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells.Pulmonary toxicity and global gene expression changes in response to sub-chronic inhalation exposure to crystalline silica in rats.Simultaneous sensitive detection of multiple DNA glycosylases from lung cancer cells at the single-molecule level.SPOP promotes transcriptional expression of DNA repair and replication factors to prevent replication stress and genomic instability
P2860

DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer.

Item
http://www.wikidata.org/entity/Q38893748
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
DNA damage signalling barrier, ...... sion of human prostate cancer.
@en
type
label
DNA damage signalling barrier, ...... sion of human prostate cancer.
@en
prefLabel
DNA damage signalling barrier, ...... sion of human prostate cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
DNA damage signalling barrier, ...... sion of human prostate cancer.
@en
P2093
P2860
P304
P31
P356
10.1016/J.MOLONC.2016.02.005
P433
P478
P50
P577
P698
P921
P932